The human drug trial market in India is today reportedly worth USD 400 million. And it is growing at a compounded annual rate of 30%! Till 1990s most clinical research was carried out in academic medical centres, paid for by government money. However, globalization and its economic twin, liberalization changed the scenario dramatically. Commercial interests now rule and financial bottom-lines override ethical and human rights concerns, with predictable results. Read the full document here: 
/uploads/8/7/6/4/8764189/regulation_of_drug_and_clinical_trials_in_india.pdf